Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Parnell (AquaFOL, Pamlin, Ketamine, Methone, KEY and Imidox)

M&A STATUS
Buyout/LBO LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

Manufacturer of veterinary products. The company is engaged in producing medication which are primarily used for starting and maintaining anesthesia among pets in Australia.

Ownership Status
Acquired/Merged
Financing Status
Private Equity-Backed
Primary Industry
Pharmaceuticals
Primary Office
  • PO Box 1035
  • Mascot, New South Wales 1460
  • Australia

Parnell (AquaFOL, Pamlin, Ketamine, Methone, KEY and Imidox) Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Parnell (AquaFOL, Pamlin, Ketamine, Methone, KEY and Imidox)‘s full profile, request access.

Request full access to PitchBook

Parnell (AquaFOL, Pamlin, Ketamine, Methone, KEY and Imidox) Former Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Parnell (AquaFOL, Pamlin, Ketamine, Methone, KEY and Imidox)‘s full profile, request access.

Request full access to PitchBook